Pathkey.ai Limited has released a press release.
Opyl - Additional Commentary March Quarter 2020
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Pathkey.AI
- Opyl receives $201K R&D incentive and tax refund
- Opyl - Business Update & Half Year Report
- Response to ASX Appendix 4C Query
- Opyl develops clinical trial prediction software using AI
- Opyl partners with hummun
Later from Pathkey.AI
- Opyl and AAMRI launch COVID-19 Social Media Guide
- Opyl - Updated March Quarter Appendix 4C
- Opyl - Commercial Update
- Opyl - Additional Information for 20 May Announcement
- Opyl - Completes Capital Raise
Follow Pathkey.AI into a list and get an email when it puts out news.
Follow Pathkey.AI